Xinxiang Medical Univeisity, Xinxiang, China.
Puyang Oilfield General Hospital, Puyang, China.
Medicine (Baltimore). 2024 Mar 8;103(10):e37442. doi: 10.1097/MD.0000000000037442.
Genetic factors contribute to chronic kidney disease (CKD) and end-stage renal disease (ESRD). Advances in genetic testing have enabled the identification of hereditary kidney diseases, including those caused by LMX1B mutations. LMX1B mutations can lead to nail-patella syndrome (NPS) or nail-patella-like renal disease (NPLRD) with only renal manifestations.
The proband was a 13-year-old female who was diagnosed with nephrotic syndrome at the age of 6. Then she began intermittent hormone and drug therapy. When she was 13 years old, she was admitted to our hospital due to sudden chest tightness, which progressed to end-stage kidney disease (ESRD), requiring kidney replacement therapy. Whole-Exome Sequencing (WES) results suggest the presence of LMX1B gene mutation, c.737G > T, p.Arg246Leu. Tracing her family history, we found that her father, grandmother, uncle and 2 cousins all had hematuria, or proteinuria. In addition to the grandmother, a total of 9 members of the family performed WES. The members with kidney involved all carry the mutated gene. Healthy members did not have the mutated gene. It is characterized by co-segregation of genotype and phenotype. We followed the family for 9 year, the father developed ESRD at the age of 50 and started hemodialysis treatment. The rest patients had normal renal function. No extra-renal manifestations associated with NPS were found in any member of the family.
This study has successfully identified missense mutation, c.737G > T (p.Arg246Leu) in the homeodomain, which appears to be responsible for isolated nephropathy in the studied family. The arginine to leucine change at codon 246 likely disrupts the DNA-binding homeodomain of LMX1B. Previous research has documented 2 types of mutations at codon R246, namely R246Q and R246P, which are known to cause NPLRD. The newly discovered mutation, R246L, is likely to be another novel mutation associated with NPLRD, thus expanding the range of mutations at the crucial renal-critical codon 246 that contribute to the development of NPLRD. Furthermore, our findings suggest that any missense mutation occurring at the 246th amino acid position within the homeodomain of the LMX1B gene has the potential to lead to NPLRD.
遗传因素导致慢性肾脏病(CKD)和终末期肾病(ESRD)。遗传检测技术的进步使得遗传性肾脏疾病的鉴定成为可能,包括 LMX1B 基因突变引起的疾病。LMX1B 基因突变可导致指甲髌骨综合征(NPS)或仅表现为肾脏疾病的指甲髌骨样肾病(NPLRD)。
先证者为一名 13 岁女性,6 岁时被诊断为肾病综合征。此后,她开始间歇性接受激素和药物治疗。13 岁时,她因突发胸闷,进展为终末期肾病(ESRD),需要肾脏替代治疗而入院。全外显子组测序(WES)结果提示存在 LMX1B 基因突变,c.737G>T,p.Arg246Leu。追查家族史,发现其父亲、奶奶、叔叔和 2 个表亲均有血尿或蛋白尿。除奶奶外,家族中共有 9 人进行了 WES 检测。有肾脏受累的成员均携带突变基因。健康成员未携带突变基因。该家系表现为基因型与表型共分离。我们对该家系进行了 9 年的随访,父亲在 50 岁时发展为 ESRD,并开始血液透析治疗。其余患者肾功能正常。家系成员均无 NPS 相关的肾脏外表现。
本研究成功鉴定了在家系中引起孤立性肾病的错义突变 c.737G>T(p.Arg246Leu)。位于密码子 246 的精氨酸向亮氨酸的改变可能破坏了 LMX1B 的 DNA 结合同源域。先前的研究已证实 R246 密码子的 2 种突变 R246Q 和 R246P 可导致 NPLRD。新发现的 R246L 突变可能是另一种与 NPLRD 相关的新突变,从而扩展了导致 NPLRD 的关键肾关键密码子 246 处突变的范围。此外,我们的研究结果表明,LMX1B 基因同源域第 246 位氨基酸发生的任何错义突变都可能导致 NPLRD。